This study is looking at whether a medication called Tamsulosin can help women recover faster from urinary retention (difficulty emptying your bladder) after pelvic reconstructive surgery. You might be able to join if you are 18 or older, can speak and read English, and have urinary retention after your surgery. The study compares Tamsulosin to a placebo (an inactive pill that looks the same) to see if Tamsulosin shortens how long you experience urinary retention. Researchers also want to see if it leads to fewer urinary tract infections and a better quality of life. The study is currently unclear on its recruitment status, but plans to enroll 154 women.

Study design

This is a double-blind, randomized, placebo-controlled study, meaning neither you nor your doctor will know if you're receiving Tamsulosin or the placebo. It plans to include 154 women.

What's involved

If you join, you will take 10 capsules daily of either Tamsulosin or a placebo until your urinary retention resolves or for up to 10 days.

Compensation

Not stated in the trial record.

Follow-up

The study will track how long your urinary retention lasts, up to a 10-day course.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.